CELU יחס מהיר Celularity Inc

The price action of Celularity Inc. (CELU) on the GURU.Markets platform, where the liquidity ratio is 0.10, illustrates activities regarding the application of placental cells in the fight against cancer and immune pathologies. The business relies on patented cryopreservation of biomaterials to ensure the longevity of its products. However, costly clinical trials and a shortage of free cash flow amid low current revenue remain serious challenges.

For the biotechnology business of Celularity Inc. (CELU), which operates its own placental cell processing plant, the quick liquidity time series serves as an indicator of the ability to maintain its cancer therapy platform without selling off inventories. This metric offsets cash and accounts receivable against short-term liabilities, excluding illiquid warehouse stocks to assess real solvency and minimize the risk of cash flow gaps.